Travere Therapeutics, Inc. Common Stock (NASDAQ: TVTX) last traded at $65.71, up 1.94% on the session. The quote above updates while this page is open; the figures below are drawn from Travere Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Travere Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker TVTX. Its market capitalisation is $6.19 billion.
Valuation measures for Travere Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $6.19B |
|---|---|
| Enterprise value | $6.85B |
| Price / sales | 10.47 |
| Price / book | 252.59 |
| Beta | 1.51 |
Trailing-twelve-month figures tagged in Travere Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $591.33M |
|---|---|
| Net income (TTM) | -$43.46M |
| EPS (TTM) | -$0.450 |
| Operating margin | -6.84% |
| Return on equity | -177.24% |
| Cash | $117.73M |
Range and volume for TVTX over the past 52 weeks.
| 52-week high | $66.38 |
|---|---|
| 52-week low | $17.05 |
| Volume | 1.47M |
| Average volume | 1.86M |
| Previous close | $64.46 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.